• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症治疗中的生物纳米载体:精准给药的前沿创新

Biological Nanocarriers in Cancer Therapy: Cutting Edge Innovations in Precision Drug Delivery.

作者信息

Ganpisetti Ramesh, Giridharan Sanjay, Vaskuri G S Sainaga Jyothi, Narang Nikesh, Basim Pratap, Dokmeci Mehmet Remzi, Ermis Menekse, Rojekar Satish, Gholap Amol D, Kommineni Nagavendra

机构信息

Terasaki Institute of Biomedical Sciences, 21100 Erwin St, Woodland Hills, Los Angeles, CA 91367-3712, USA.

Arizona State University, 1151 S. Forest AV Tempe, Tempe, AZ 85281, USA.

出版信息

Biomolecules. 2025 May 31;15(6):802. doi: 10.3390/biom15060802.

DOI:10.3390/biom15060802
PMID:40563442
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12191216/
Abstract

Cancer is a highly detrimental and fatal illness that poses a significant threat to human well-being. The pattern of cancer treatment is continuously being optimized by the advancement of old treatment approaches and the invention of novel treatment modes. Nanotechnology-based approaches are emerging as powerful candidates in the development of these advanced methods for treating tumors. This article provides a concise overview of nanotechnology for cancer or cancer nanomedicine and its applications. In light of prevalent issues, such as inadequate precision in targeting initial chemotherapy drugs, susceptibility of nucleic acid drugs to degradation, gene delivery, and the occurrence of common immune-related adverse events during immunotherapy, we explore the potential integration of nanomedicine with these treatment approaches and illustrative examples and highlight the benefits that arise from the utilization of nanomedicine.

摘要

癌症是一种极具危害性和致命性的疾病,对人类健康构成重大威胁。随着传统治疗方法的进步和新型治疗模式的发明,癌症治疗模式在不断优化。基于纳米技术的方法正成为开发这些先进肿瘤治疗方法的有力候选者。本文简要概述了用于癌症治疗的纳米技术或癌症纳米医学及其应用。鉴于一些普遍存在的问题,如初始化疗药物靶向精准度不足、核酸药物易降解、基因递送以及免疫治疗期间常见免疫相关不良事件的发生等,我们探讨了纳米医学与这些治疗方法潜在的结合方式及实例,并强调了利用纳米医学所带来的益处。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74b9/12191216/7621b854d889/biomolecules-15-00802-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74b9/12191216/e7575e45377a/biomolecules-15-00802-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74b9/12191216/0de91a7701be/biomolecules-15-00802-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74b9/12191216/a68af7e3340a/biomolecules-15-00802-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74b9/12191216/bbe705b4d280/biomolecules-15-00802-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74b9/12191216/d514a2157013/biomolecules-15-00802-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74b9/12191216/7621b854d889/biomolecules-15-00802-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74b9/12191216/e7575e45377a/biomolecules-15-00802-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74b9/12191216/0de91a7701be/biomolecules-15-00802-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74b9/12191216/a68af7e3340a/biomolecules-15-00802-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74b9/12191216/bbe705b4d280/biomolecules-15-00802-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74b9/12191216/d514a2157013/biomolecules-15-00802-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74b9/12191216/7621b854d889/biomolecules-15-00802-g006.jpg

相似文献

1
Biological Nanocarriers in Cancer Therapy: Cutting Edge Innovations in Precision Drug Delivery.癌症治疗中的生物纳米载体:精准给药的前沿创新
Biomolecules. 2025 May 31;15(6):802. doi: 10.3390/biom15060802.
2
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
3
Polyester nanoparticles delivering chemotherapeutics: Learning from the past and looking to the future to enhance their clinical impact in tumor therapy.聚酯纳米粒子递送化疗药物:从过去中学习并展望未来,以增强其在肿瘤治疗中的临床应用。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024 Sep-Oct;16(5):e1990. doi: 10.1002/wnan.1990.
4
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
5
Mechanistic insight into nanomedicine for polycystic ovary syndrome.多囊卵巢综合征纳米药物的作用机制洞察
Mol Biol Rep. 2025 Jun 21;52(1):618. doi: 10.1007/s11033-025-10709-7.
6
Hyaluronic acid-based drug nanocarriers as a novel drug delivery system for cancer chemotherapy: A systematic review.基于透明质酸的药物纳米载体作为癌症化疗的新型药物递送系统:系统评价。
Daru. 2021 Dec;29(2):439-447. doi: 10.1007/s40199-021-00416-6. Epub 2021 Sep 9.
7
Antiemetics for adults for prevention of nausea and vomiting caused by moderately or highly emetogenic chemotherapy: a network meta-analysis.成人止吐药预防中度或高度致吐性化疗引起的恶心和呕吐:网状荟萃分析。
Cochrane Database Syst Rev. 2021 Nov 16;11(11):CD012775. doi: 10.1002/14651858.CD012775.pub2.
8
EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update.欧洲癌症研究与治疗组织(EORTC)癌症贫血患者促红细胞生成蛋白使用指南:2006年更新版
Eur J Cancer. 2007 Jan;43(2):258-70. doi: 10.1016/j.ejca.2006.10.014. Epub 2006 Dec 19.
9
Interventions for fertility preservation in women with cancer undergoing chemotherapy.对接受化疗的癌症女性进行生育力保存的干预措施。
Cochrane Database Syst Rev. 2025 Jun 19;6:CD012891. doi: 10.1002/14651858.CD012891.pub2.
10
Nivolumab for adults with Hodgkin's lymphoma (a rapid review using the software RobotReviewer).纳武单抗用于成人霍奇金淋巴瘤(使用RobotReviewer软件进行的快速综述)
Cochrane Database Syst Rev. 2018 Jul 12;7(7):CD012556. doi: 10.1002/14651858.CD012556.pub2.

引用本文的文献

1
Advanced Nanomaterials Functionalized with Metal Complexes for Cancer Therapy: From Drug Loading to Targeted Cellular Response.用于癌症治疗的金属配合物功能化先进纳米材料:从药物负载到靶向细胞反应
Pharmaceuticals (Basel). 2025 Jul 3;18(7):999. doi: 10.3390/ph18070999.

本文引用的文献

1
DNA-Based Nanostructured Platforms as Drug Delivery Systems.基于DNA的纳米结构平台作为药物递送系统
Chem Bio Eng. 2024 Jan 9;1(3):179-198. doi: 10.1021/cbe.3c00023. eCollection 2024 Apr 25.
2
DNA origami-based composite nanosandwich for iteratively potentiated chemo-immunotherapy.用于迭代增强化学免疫疗法的基于DNA折纸的复合纳米三明治结构
J Control Release. 2025 Mar 10;379:452-465. doi: 10.1016/j.jconrel.2025.01.031. Epub 2025 Jan 17.
3
Therapeutic Antisense Oligonucleotides in Oncology: From Bench to Bedside.肿瘤学中的治疗性反义寡核苷酸:从实验台到病床边
Cancers (Basel). 2024 Aug 23;16(17):2940. doi: 10.3390/cancers16172940.
4
New Opportunities and Old Challenges in the Clinical translation of Nanotheranostics.纳米诊疗临床转化中的新机遇与旧挑战
Nat Rev Mater. 2023 Dec;8(12):783-798. doi: 10.1038/s41578-023-00581-x. Epub 2023 Jul 26.
5
Nanocarriers of antigen proteins for vaccine delivery.抗原蛋白的纳米载体用于疫苗传递。
Int J Pharm. 2024 Jun 25;659:124162. doi: 10.1016/j.ijpharm.2024.124162. Epub 2024 Apr 24.
6
Lipid-based nanoparticles as drug delivery carriers for cancer therapy.基于脂质的纳米颗粒作为癌症治疗的药物递送载体。
Front Oncol. 2024 Apr 10;14:1296091. doi: 10.3389/fonc.2024.1296091. eCollection 2024.
7
A review of DNA nanoparticles-encapsulated drug/gene/protein for advanced controlled drug release: Current status and future perspective over emerging therapy approaches.DNA 纳米颗粒包裹药物/基因/蛋白质用于先进的控制药物释放的综述:新兴治疗方法的现状和未来展望。
Int J Biol Macromol. 2024 May;268(Pt 1):131694. doi: 10.1016/j.ijbiomac.2024.131694. Epub 2024 Apr 18.
8
DNA nanodevice as a multi-module co-delivery platform for combination cancer immunotherapy.DNA 纳米器件作为一种多模块共递药平台用于联合癌症免疫治疗。
J Colloid Interface Sci. 2024 Aug;667:1-11. doi: 10.1016/j.jcis.2024.04.069. Epub 2024 Apr 13.
9
Nucleic acid-based drugs for patients with solid tumours.用于实体瘤患者的核酸类药物。
Nat Rev Clin Oncol. 2024 Jun;21(6):407-427. doi: 10.1038/s41571-024-00883-1. Epub 2024 Apr 8.
10
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.